Patterson Leone D insider trades
Patterson Leone D has filed 16 Form 4s with the SEC that we hold, for Nkarta, Inc. (NKTX) (Director), Tenaya Therapeutics, Inc. (TNYA) (Chief Fin. and Bus. Officer), Zymeworks Inc. (ZYME) (EVP, Chief Bus & Fin Officer) and Kalaris Therapeutics, Inc. (KLRS) (Director), among 5 companies in all. Across all of them we count 0 purchases worth $0 and 2 sales worth $47.4K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 5,201 shares of Tenaya Therapeutics, Inc. worth $30.5K, dated 2024-02-16. The first filing on our record is dated 2022-02-17 and the latest 2026-06-11.
Nkarta, Inc. (NKTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Tenaya Therapeutics, Inc. (TNYA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-16 | S, sale reported on Form 4 | 4,452 | $17.0K | 2023-08-18 |
| 2024-02-16 | S, sale reported on Form 4 | 5,201 | $30.5K | 2024-02-16 |
Zymeworks Inc. (ZYME)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Kalaris Therapeutics, Inc. (KLRS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Climb Bio, Inc. (ELYM)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1233539) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms